Angelo Gordon & Co’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

Angelo Gordon & Co’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-200,000	Closed	-$1.66M	–	98
2020 Q2	$1.66M	Hold	200,000	–	–	0.23%	53
2020 Q1	$1.65M	Hold	200,000	–	–	0.12%	57
2019 Q4	$2M	Buy	+200,000	New	+$282K	0.31%	50

Other funds holding NFH.WS

BCM

BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

MAM

Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $8.89B AUM 39.91% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $871M AUM 8.61% 1-Year Est. Return

Angelo Gordon & Co's NFH.WS Position: Q3 2020 in Review

Angelo Gordon & Co sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q3 2020, closing a stake of 200,000 shares — an estimated $1.66M sold.

Angelo Gordon & Co first reported a position in NFH.WS in Q4 2019 and held it in 3 quarters. The position peaked at $2M in Q4 2019. 16 funds tracked by Wall St. Rank hold NFH.WS as of Q3 2020.

Angelo Gordon & Co reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q3 2020 after selling out during the quarter.
Angelo Gordon & Co sold 200,000 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q3 2020, an estimated $1.66M.
Angelo Gordon & Co first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q4 2019 and held it in 3 quarters.
Angelo Gordon & Co's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $2M in Q4 2019.
16 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q3 2020.

Based on Angelo Gordon & Co's 13F filing for Q3 2020, filed 16 Nov 2020.